Company Profile
CEO
Ms. Kristin C. Peck(CEO & Director)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
14.5K
Beta
0.74
Forward P/E
10.6
52W High
$171.52
52W Low
$72.38
Profit Margin
28.0%
Operating Margin
36.6%
Return on Equity
67.8%
Revenue Growth
2.9%
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commer...
Valuation
Market Cap$33.05B
P/E (TTM)12.92
P/S (TTM)3.65
EV/EBITDA--
Cash Flow
FCF Yield+3.5%
SBC Adj. FCF Yield+3.2%
SBC Impact8.6%
Margins & Growth
Profit Margin26.6%
Operating Margin--
Revenue YoY2.9%
Earnings YoY-0.2%
Balance
Cash$1.94B
Debt$9.04B
Net Cash$-7.10B
Dividend
Dividend Yield2.71%
Payout Ratio37.3%
Quarterly Payout$224.00M